Gayle Furgurson Wellborn - 26 Jun 2025 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Director
Signature
/s/ Michael Newton, Attorney-in-Fact
Issuer symbol
HQY
Transactions as of
26 Jun 2025
Net transactions value
$0
Form type
4
Filing time
30 Jun 2025, 17:59:15 UTC
Previous filing
11 Jul 2024
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wellborn Gayle Furgurson Director C/O HEALTHEQUITY, INC., 15 W. SCENIC POINTE DR., STE. 100, DRAPER /s/ Michael Newton, Attorney-in-Fact 30 Jun 2025 0001712960

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Award $0 +2,003 +11% $0.000000 19,733 26 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HQY Stock Option (right to buy) 2,439 26 Jun 2025 Common Stock 2,439 $47.21 Direct F2
holding HQY Stock Options (right to buy) 4,339 26 Jun 2025 Common Stock 4,339 $50.41 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's next annual stockholder meeting. Vested shares will be delivered to the reporting person upon vesting.
F2 The option is immediately exercisable.

Remarks:

The Power of Attorney given by Ms. Wellborn was previously filed with the U.S. Securities and Exchange Commission on June 26, 2023, as an exhibit to a statement on Form 4 filed by Ms. Wellborn with respect to HealthEquity, Inc. and is hereby incorporated by reference.